James D. Neaton

Active 1981–2024

126
Papers
51,252
Citations
92
h-index
124
i10-index

Citations

Citations per year for James D. Neaton1979: 1 citations1981: 4 citations1982: 2 citations1983: 1 citations1984: 2 citations1986: 18 citations1987: 18 citations1988: 17 citations1989: 35 citations1990: 22 citations1991: 67 citations1992: 63 citations1993: 79 citations1994: 85 citations1995: 118 citations1996: 141 citations1997: 167 citations1998: 178 citations1999: 164 citations2000: 238 citations2001: 250 citations2002: 253 citations2003: 317 citations2004: 331 citations2005: 343 citations2006: 294 citations2007: 292 citations2008: 295 citations2009: 316 citations2010: 309 citations2011: 311 citations2012: 353 citations2013: 364 citations2014: 332 citations2015: 283 citations2016: 250 citations2017: 223 citations2018: 187 citations2019: 726 citations2020: 1,619 citations2021: 1,818 citations2022: 968 citations2023: 475 citations2024: 623 citations2025: 222 citations2026: 9 citations1980: no citations, so this year is not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,904 citing papers, 29.6% of this breakdownUnited Kingdom: 1,646 citing papers, 8.2% of this breakdownItaly: 910 citing papers, 4.6% of this breakdownGermany: 815 citing papers, 4.1% of this breakdownChina: 786 citing papers, 3.9% of this breakdownCanada: 775 citing papers, 3.9% of this breakdownFrance: 721 citing papers, 3.6% of this breakdownAustralia: 684 citing papers, 3.4% of this breakdownNetherlands: 564 citing papers, 2.8% of this breakdownJapan: 533 citing papers, 2.7% of this breakdownSpain: 527 citing papers, 2.6% of this breakdownIndia: 381 citing papers, 1.9% of this breakdown
0%29.6%Other 28.7%

Fields

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Immunology and Microbiology4.1%
  • Computer Science2.4%
  • Nursing2.3%
  • Social Sciences1.4%
  • Other6.7%

Topics

  • COVID-19 Clinical Research Studies6.2%
  • SARS-CoV-2 and COVID-19 Research5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.6%
  • Blood Pressure and Hypertension Studies3.1%
  • Lipoproteins and Cardiovascular Health2.5%
  • Long-Term Effects of COVID-192.5%
  • Other77.1%

Coauthors

All papers

Open in search
  1. Remdesivir for the Treatment of Covid-19 — Final Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdel G. Babiker, Sarah Pett, James D. Neaton, Timothy Burgess, Tyler Bonnett, Michelle Green, Mat Makowski, Anu Osinusi, Seema Nayak, H. Clifford Lane - New England Journal of Medicine 2020 cited by 7,730

  2. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

    Authors: , , , , , , , , , - New England Journal of Medicine 2003 cited by 4,920

  3. The Prevention and Treatment of Missing Data in Clinical Trials

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,891

  4. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    Authors: , , , , , , , , - Circulation 1989 cited by 3,187

  5. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2011 cited by 1,106

  6. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jarrod M. Mosier, Michelle N. Gong, David J. Douin, R. Duncan Hite, Barbara W. Trautner, Mamta K. Jain, Edward M. Gardner, Akram Khan, Jens-Ulrik Jensen, Michael A. Matthay, Adit A. Ginde, Samuel M. Brown, Elizabeth S. Higgs, Sarah Pett, Amy C. Weintrob, Christina C. Chang, Daniel D. Murrary, Huldrych F. Günthard, Ellen Moquete, Greg Grandits, Nicole Engen, Birgit Grund, Shweta Sharma, Huyen Cao, Rajesh Gupta, Suzette Osei, David Margolis, Qing Zhu, Mark N. Polizzotto, Abdel G. Babiker, Victoria J. Davey, Virginia Kan, B. Taylor Thompson, Annetine C. Gelijns, James D. Neaton, H. Clifford Lane, Jens D. Jundgren, John Tierney, Kevin Barrett, Betsey R. Herpin, Mary C. Smolskis, Susan E. Voge, Laura A. McNay, Kelly Cahill, Page Crew, Matthew Kirchoff, Ratna Sardana, Sharon Segal Raim, Joseph Chiu, Lisa Hensley, Josua Lorenzo, Rebecca Mock, Katy Shaw-Saliba, Judith Zuckerman, Stacey J. Adam, Judy Currier, Sarah Read, Eric Hughes, Laura Amos, Amy Carlsen, Anita Carter, Bionca Davis, Eileen Denning, Alain DuChene, Merrie Harrison, Payton Kaiser, Joseph Koopmeiners, Sue Meger, Thomas Murray, Kien Quan and 547 more - The Lancet Infectious Diseases 2021 cited by 194

  7. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

    Authors: , , , , , , , , , , , , - PLoS Medicine 2008 cited by 1,607

  8. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

    Authors: , , , , , , , , , , - The Lancet 2009 cited by 645

  9. Blood Pressure and End-Stage Renal Disease in Men

    Authors: , , , , , , , - New England Journal of Medicine 1996 cited by 1,660

  10. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

    Authors: , , , - Diabetes Care 1993 cited by 4,098

  11. Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 342

  12. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

    Authors: , , , , , , , , , , - PLoS ONE 2016 cited by 191

  13. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tomas O. Jensen MD, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane - The Lancet 2022 cited by 76

  14. Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial

    Authors: , , , , - New England Journal of Medicine 1989 cited by 1,134

  15. Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2010 cited by 869

  16. Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy

    Authors: , , , , , , , , - JAMA 1999 cited by 732

  17. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 253

  18. Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

    Authors: , , , , , - Journal of the American Heart Association 2014 cited by 222

  19. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection

    Authors: , , , , , , , , , - The Journal of Infectious Diseases 2016 cited by 127

  20. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah Pett, Srikanth Ramachandruni, M. Tauseef Rehman, Brad T. Sherman, D. Clark Files, Samuel M. Brown, Michael A. Matthay, B. Taylor Thompson, James D. Neaton, H. Clifford Lane, Jens D. Lundgren, Angela J. Rogers, Deborah Wentworth, Andrew Phillips, Kathryn Shaw‐Saliba, Robin Dewar, Neil R. Aggarwal, Abdel G. Babiker, Weizhong Chang, Nila J. Dharan, Victoria J. Davey, Elizabeth S. Higgs, Norman Gerry, Adit A. Ginde, J.W. Awori Hayanga, Helene Highbarger, Jeroen Highbarger, Mamta K. Jain, Virginia L. Kan, Kami Kim, Perrine Lallemand, Bradley G. Leshnower, Joseph Lutaakome, Gail Matthews, Ahmad Mourad, Eleftherios Mylonakis, Ven Natarajan, María L. Padilla, Lavannya M. Pandit, Roger Paredes, Sarah Pett, Srikanth Ramachandruni, M. Tauseef Rehman, Brad T. Sherman, D. Clark Files, Samuel M. Brown, Michael A. Matthay, B. Taylor Thompson, James D. Neaton, H. Clifford Lane, Jens D. Lundgren, David Sahner, John Tierney, Susan Vogel, Betsey Herpin, Mary Smolskis, Laura A McKay, Kelly Cahill, Page Crew, Ratna Sardana, Sharon Segal Raim, Lisa Hensely, J. Ponce Lorenzo, Rebecca Mock, Judith Zuckerman, Negin Atri, Mark D. Miller, David Vallée, Lucy Chung, Nayon Kang and 1,382 more - Annals of Internal Medicine 2022 cited by 63

  21. Report of the Conference on Low Blood Cholesterol: Mortality Associations.

    Authors: , , , , , , , , , - Circulation 1992 cited by 736

  22. The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction

    Authors: , , , , , , , , , , , - Cardiovascular Drugs and Therapy 2001 cited by 361

  23. Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death

    Authors: , , , , , , , , , - The Journal of Infectious Diseases 2011 cited by 315

  24. Methodological Issues in Cohort Studies That Relate Sodium Intake to Cardiovascular Disease Outcomes

    Authors: , , , , , , , , - Circulation 2014 cited by 307